The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals (Q33505475)

27 July 2017

The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals (English)

1 reference

27 July 2017

anti-retroviral agent

0 references

0 references

9

Ard van Sighem

1 reference

27 July 2017

7

Caroline Sabin

0 references

Dominique Costagliola

11

Dominique Costagliola

0 references

Emilie Lanoy

12

Emilie Lanoy

0 references

Julia del Amo

Julia del Amo

ORCID Public Data File 2021

17

0 references

0 references

0 references

1 reference

Maria José Amengual

1 reference

ORCID Public Data File 2021

Marta M Alonso

1 reference

ORCID Public Data File 2021

Andrew N Phillips

22

Andrew Phillips

1 reference

27 July 2017

19

Amy Justice

1 reference

27 July 2017

4

Jonathan A C Sterne

1 reference

27 July 2017

HIV-CAUSAL Collaboration

1

1 reference

27 July 2017

Maile Ray

2

1 reference

27 July 2017

Roger Logan

3

1 reference

27 July 2017

Sonia Hernández-Díaz

5

1 reference

27 July 2017

James M Robins

6

1 reference

27 July 2017

Loveleen Bansi

8

1 reference

27 July 2017

Frank de Wolf

10

1 reference

27 July 2017

Heiner C Bucher

13

1 reference

27 July 2017

Viktor von Wyl

14

1 reference

27 July 2017

Anna Esteve

15

1 reference

27 July 2017

Jordi Casbona

16

1 reference

27 July 2017

Santiago Moreno

18

1 reference

27 July 2017

Joseph Goulet

20

1 reference

27 July 2017

Sara Lodi

21

1 reference

27 July 2017

Rémonie Seng

23

1 reference

27 July 2017

Laurence Meyer

24

1 reference

27 July 2017

Santiago Pérez-Hoyos

25

1 reference

27 July 2017

Patricia García de Olalla

26

1 reference

27 July 2017

Miguel A Hernán

27

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

27 July 2017

1 reference

27 July 2017

24

1 reference

27 July 2017

123-137

1 reference

27 July 2017

1

1 reference

Distinct genetic loci control plasma HIV-RNA and cellular HIV-DNA levels in HIV-1 infection: the ANRS Genome Wide Association 01 study

27 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Survival following HIV infection of a cohort followed up from seroconversion in the UK.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Veterans Aging Cohort Study (VACS): Overview and description

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Survival and progression to AIDS in a seroconverter cohort in the post-highly active antiretroviral therapy era: effectiveness goes on.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

A structural approach to selection bias

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Mortality and progression to AIDS after starting highly active antiretroviral therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: differences by transmission category

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Spanish cohort of naïve HIV-infected patients (CoRIS): rationale, organization and initial results

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Survival of persons with and without HIV infection in Denmark, 1995-2005.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

HIV survival benefit associated with earlier antiviral therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

Evaluating the role of CD4-lymphocyte counts as surrogate endpoints in human immunodeficiency virus clinical trials

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2920287

The UK register of HIV seroconverters: methods and analytical issues. UK register of HIV seroconverters (UKRHS) Steering Committee

31 October 2018

1 reference

12 December 2020

Surrogacy in HIV-1 clinical trials

1 reference

12 December 2020

CD4 cell count as a surrogate endpoint in HIV clinical trials: a meta-analysis of studies of the AIDS Clinical Trials Group

1 reference

12 December 2020

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

12 December 2020

An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group

1 reference

12 December 2020

Does transient HAART during primary HIV-1 infection lower the virological set-point?

1 reference

12 December 2020

Mortality among urban drug users and the impact of highly active antiretroviral therapy

1 reference

12 December 2020

1 reference

12 December 2020

Effect of Highly Active Antiretroviral Therapy on Time to Acquired Immunodeficiency Syndrome or Death using Marginal Structural Models

1 reference

12 December 2020

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

1 reference

12 December 2020

CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine

1 reference

12 December 2020

[Mortality rate of HIV-infected adults compared with the general population: long-term and CD4-lymphocyte-dependent results]

1 reference

12 December 2020

10.1097/QAD.0B013E3283324283

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference